Clinical Trial Detail

NCT ID NCT01947608
Title Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Recruitment Available
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Ceritinib

Age Groups: adult

Additional content available in CKB BOOST